Post Profile






Extending dosing intervals reduces deadly side effect risk from multiple sclerosis drug

(NYU Langone Health / NYU School of Medicine) A commonly-prescribed multiple sclerosis (MS) infusion medication, natalizumab, linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists at NYU Langone Health.
read more

share

Related Posts


A Drug To Reduce The Side Effects Of A Multiple Sclerosis Treatment

Health : Medical News Today

The drug FTY720 is approved for the treatment of multiple sclerosis. Although highly effective it can have serious side effects, including reduced lung function and fluid accumulation in the eye. Understanding the multiple molecular...

Research Brings New Hope To Multiple Sclerosis Patients

Health : Medical News Today

Researchers at Aurora St. Luke's Medical Center have developed a technique that counteracts an unusual, but serious, side effect from natalizumab (Tysabri(R)), a drug that fights multiple sclerosis (MS). The side effect is a brain v...

Transcranial direct current stimulation reduces fatigue associated with multiple sclerosis

Health : EurekAlert: Health

(NYU Langone Health / NYU School of Medicine) People with multiple sclerosis (MS) who underwent a non-invasive form of electrical brain stimulation, called transcranial direct current stimulation, or tDCS, experienced significant re...

tDCS combined with computer games at home reduces cognitive symptoms of multiple sclerosis

Health : EurekAlert: Health

(NYU Langone Medical Center / New York University School of Medicine) Led by researchers at NYU Langone's Multiple Sclerosis Comprehensive Care Center, a new study reports that participants with multiple sclerosis who used tDCS whil...

Extending Treatment Up To Eight Weeks With Infusion Medication Shown Safe and Effective in Patients with Multiple Sclerosis

Health : Newswise Medical News

Extending the dose of an infusion medication for multiple sclerosis (MS), Natalizumab, from 4 weeks up to 8 has been shown to be well-tolerated and effective -- and resulted in no cases of the potentially fatal side effect, progress...

Comments


Copyright © 2016 Regator, LLC